/Investor DB

Andera Partners — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Arvelle Therapeuticsangelinipharma.chinFeb 2019 · $180M

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.

BiotechConsumerHealthtechZug, CH

Co-investorsF-Prime CapitalH.I.G. BioHealth PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersNovaQuest Capital Management, L.L.C.BRV Capital Management+1 more

Atlantic Therapeuticscalderamedical.comJan 2019

Caldera Medical develops surgical solutions for women's health conditions including stress urinary incontinence, pelvic organ prolapse, polyps, and fibroids.

FemTechHealthtechMedical Devices

Co-investorsBorski FundSeroba Life SciencesAtlantic Bridge VenturesBek VenturesEarlybird Venture CapitalEQT Life Sciences

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.